Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 2004

View Archived Issues

Characterization of dual TACE/MMP inhibitor for rheumatoid arthritis treatment

OPi completes restructuring

BioXell and ProSkelia join efforts in osteoporosis drug discovery

Pfizer completes tender offer for Esperion Therapeutics' common shares

GTC restructures

DOR BioPharma updates status of ricin vaccine development program

Dynavax licenses immunotherapy programs to UCB

P&G licenses topical antiinfective technology to GMP Companies

Senju claims new chymase and/or tryptase inhibitors and their use

Pharmacia scientists report novel telomerase inhibitors in a recent patent

Novel androgen receptor agonists under study at Kaken

Kyowa Hakko presents new antidiabetic agents

Dual D2/5-HT1A agonists with potential in Parkinson's disease therapy

New ACAT and LDL oxidation inhibitors reported by Sankyo scientists

Nippon Kayaku claims a novel antineoplastic antibiotic from Streptomyces sp.

Takeda researchers prepare and test triazole-based DPP-IV inhibitors

Genasense NDA accepted for review

Enrollment completed in confirmatory phase III trial of Prestara

Replagal receives Canadian approval

PA-457 IND cleared for initiation of clinical trials

Antares receives milestone payment from Pfizer licensing agreement

Keryx completes acquisition of Access Oncology

Fourth phase II trial for AMD-3100 underway

Update on single-agent Triapine phase II trials

Comparable results in phase II head-to-head study of TA-1790 and Viagra

SPA agreement for PRECISE trial with IL13-PE38QQR, program accepted for FDA CMA Pilot 2 program

Good safety profile found for CAT-192 in diffuse systemic sclerosis

Studies demonstrate efficacy of Tri-Luma in melasma patients

Use of infliximab in the treatment of psoriasis, dermatitis, other conditions reported at AAD

Clinical, other studies of pimecrolimus presented at dermatology congress

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...